Polytypic T-cell prolymphocytic leukemia von Ames, Erik, Silva, Oscar

Volltext

Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition von Hallett, William H.D, Ames, Erik, Motarjemi, Milad, Barao, Isabel, Shanker, Anil, Tamang, David L, Sayers, Thomas J, Hudig, Dorothy, Murphy, William J

Volltext

Murine natural killer cell licensing and regulation by T regulatory cells in viral responses von Sungur, Can M., Tang-Feldman, Yajarayma J., Ames, Erik, Alvarez, Maite, Chen, Mingyi, Longo, Dan L., Pomeroy, Claire, Murphy, William J.

Volltext

Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC von Barao, Isabel, Alvarez, Maite, Ames, Erik, Orr, Mark T., Stefanski, Heather E., Blazar, Bruce R., Lanier, Lewis L., Anderson, Stephen K., Redelman, Doug, Murphy, William J.

Volltext

Advantages and clinical applications of natural killer cells in cancer immunotherapy von Ames, Erik, Murphy, William J.

Volltext

Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturer von Ames, Erik, Bowen, Raffick A.R.

Volltext

The Authors’ Reply von Ames, Erik, Murphy, William J.

Volltext

The Authors’ Reply to TPA-2014-0477 von Ames, Erik, Murphy, William J.

Volltext

Natural Killer Cell Subsets Differentially Reject Embryonic Stem Cells Based on Licensing von Perez-Cunningham, Jessica, Ames, Erik, Smith, Rachel C, Peter, Anna K, Naidu, Ridhima, Nolta, Jan A, Murphy, William J

Volltext

NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype von Ames, Erik, Canter, Robert J, Grossenbacher, Steven K, Mac, Stephanie, Chen, Mingyi, Smith, Rachel C, Hagino, Takeshi, Perez-Cunningham, Jessica, Sckisel, Gail D, Urayama, Shiro, Monjazeb, Arta M, Fragoso, Ruben C, Sayers, Thomas J, Murphy, William J

Volltext

Natural Killer Cell Subsets Differentially Reject Embryonic Stem Cells Based on Licensing von Perez-Cunningham, Jessica, Ames, Erik, Smith, Rachel C, Peter, Anna K, Naidu, Ridhima, Nolta, Jan A, Murphy, William J

Volltext

Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance von Alvarez, Maite, Sungur, Can M, Ames, Erik, Anderson, Stephen K, Pomeroy, Claire, Murphy, William J

Volltext

Abstract 4894: Sorafenib enriches for sarcoma cancer stem cells in vitro von Canter, Robert J., Ames, Erik, Tellez, Joseph, Smith, Rachel C., Murphy, William J.

Volltext

Organ-Specific Protection By Bortezomib On The Treatment Of Cutaneous Chronic and Acute GvHD von Pai, Chien-Chun, Mirsoian, Annie, Grossenbacher, Steven, Ames, Erik, Sun, Kai, Chen, Mingyi, Blazar, Bruce R, Abedi, Mehrdad, Murphy, William J

Volltext

Immune targeting of cancer stem cells in gastrointestinal oncology von Canter, Robert J, Grossenbacher, Steven K, Ames, Erik, Murphy, William J

Volltext

The authors' reply von Ames, Erik, Murphy, William J

Volltext

The authors' reply von Ames, Erik, Murphy, William J

Volltext

Treatment of chronic graft-versus-host disease with bortezomib von Pai, Chien-Chun Steven, Chen, Mingyi, Mirsoian, Annie, Grossenbacher, Steven K., Tellez, Joseph, Ames, Erik, Sun, Kai, Jagdeo, Jared, Blazar, Bruce R., Murphy, William J., Abedi, Mehrdad

Volltext

Human and mouse natural killer cell cytotoxicity towards embryonic stem cells (169.41) von Peter, Anna, Ames, Erik, Zhou, Ping, Nolta, Jan, Murphy, William

Volltext

Low-Dose Sorafenib Promotes Cancer Stem Cell Expansion and Accelerated Tumor Progression in Soft Tissue Sarcomas von Cruz, Sylvia M, Iranpur, Khurshid R, Judge, Sean J, Ames, Erik, Sturgill, Ian R, Farley, Lauren E, Darrow, Morgan A, Crowley, Jiwon Sarah, Monjazeb, Arta M, Murphy, William J, Canter, Robert J

Volltext